ARALAST AATmosphere is a comprehensive support program for Alphas and their families.
One phone call puts your patient in touch with a team of healthcare and benefits specialists who can help with:
- Finding the right Home Care company
- Identifying the best fit for insurance needs
- Understanding the importance of augmentation therapy
- Learning about the infusion process
- Considering family testing
Aralast AATmosphere also puts newly diagnosed patients in touch with a team of trained advocates, all people living with AAT deficiency.
Learn about all the ways Aralast AATmosphere can help your patients and be a resource for you and your staff.
Call 1-866-ARALAST 7am-6pm Central Time or visit AATmosphere.com.
Read the Baxter News Release.
ARALAST [Alpha1-Proteinase Inhibitor (Human)] is indicated for chronic augmentation therapy in patients having congenital deficiency of A1-PI with clinically evident emphysema. ARALAST is not indicated as therapy for lung disease patients in whom congenital A1-PI deficiency has not been established.
Please review the Important Safety Information and the Full Prescribing Information
 |
To view PDF, you will need Adobe® Acrobat® Reader® software. |
